Related Experiment Video

Updated: Sep 11, 2025

Postoperative Ileus Murine Model
04:26

Postoperative Ileus Murine Model

Published on: July 12, 2024

762

Aggressive enema and surgery for meconium-related ileus in extremely low-birth-weight infants

Kenji Santo1, Yuichi Takama2, Marie Todo2

  • 1Department of Pediatric Surgery, Osaka City General Hospital, 2-13-22, Miyakojimahondori, Miyakojima-ku, Osaka, 534-0021, Japan. santokenji@gmail.com.

PubMed

Insights

An aggressive treatment strategy for meconium-related ileus (MRI) in extremely low birth weight infants (ELBWIs) significantly reduced perforation rates and improved survival. This novel protocol demonstrates enhanced outcomes for neonates with MRI.

Area of Science:

  • Neonatal surgery
  • Pediatric gastroenterology
  • Intestinal obstruction management

Background:

  • Meconium-related ileus (MRI) is a significant cause of intestinal obstruction in extremely low birth weight infants (ELBWIs).
  • Traditional management approaches have varying success rates and carry risks of complications such as perforation.
  • Optimizing treatment strategies is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

  • To evaluate the effectiveness of a novel, aggressive treatment protocol for meconium-related ileus (MRI) in extremely low birth weight infants (ELBWIs).
  • To compare outcomes between infants treated with the new protocol versus a historical control group.

Main Methods:

  • Implementation of a new protocol involving early Gastrografin injection, aggressive enema therapy, and early surgery without perforation (ES) since April 2018.
  • Retrospective comparison of 91 ELBWIs with MRI, divided into an "Old" group (n=56, pre-protocol) and a "New" group (n=35, post-protocol).
  • Analysis of patient demographics, treatment details, perforation rates, surgical intervention, and survival rates.

Main Results:

  • The "New" group exhibited significantly lower perforation rates (2.9%) compared to the "Old" group (21.4%) (p=0.014).
  • While overall surgical rates were similar (14.3% vs. 21.4%), the "New" group had a higher rate of early surgery without perforation (ES) (11.8% vs. 0%) (p=0.02).
  • The "New" group demonstrated a significantly higher overall survival rate (100%) compared to the "Old" group (87.5%) (p=0.041), with all deaths in the "Old" group linked to perforation.

Conclusions:

  • The aggressive MRI treatment protocol, including early Gastrografin and enema therapy, is effective in reducing perforation rates in ELBWIs.
  • This strategy leads to improved survival outcomes for extremely low birth weight infants suffering from meconium-related ileus.
  • The findings support the adoption of this novel protocol for managing MRI in this high-risk neonatal population.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
213
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
175
Lower GI Series: Barium Enema01:23

Lower GI Series: Barium Enema

A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
499
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
333
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
411
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
294